Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation ; volume:12 ; number:1 ; day:25 ; month:1 ; year:2024 ; pages:1-4 ; date:12.2024
Biomarker Research ; 12, Heft 1 (25.1.2024), 1-4, 12.2024
- Urheber
-
Guru Murthy, Guru Subramanian
Zhang, Tao
Bolon, Yung-Tsi
Spellman, Stephen
Dong, Jing
Auer, Paul
Saber, Wael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-023-00550-0
- URN
-
urn:nbn:de:101:1-2024040513062954261292
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guru Murthy, Guru Subramanian
- Zhang, Tao
- Bolon, Yung-Tsi
- Spellman, Stephen
- Dong, Jing
- Auer, Paul
- Saber, Wael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms